NDRA - ENDRA Life Sciences Inc.

4.38
0.840   19.178%

Share volume: 474,094
Last Updated: 04-07-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$3.54
0.84
0.24%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
18%
Profitability 0%
Dept financing 10%
Liquidity 55%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
10.89%
1 Month
29.59%
3 Months
-27.00%
6 Months
2,168.25%
1 Year
1,137.29%
2 Year
138.04%
Key data
Stock price
$4.38
P/E Ratio 
0.00
DAY RANGE
$3.61 - $6.15
EPS 
-$716.13
52 WEEK RANGE
$0.03 - $8.80
52 WEEK CHANGE
$1,115.99
MARKET CAP 
291.207 K
YIELD 
N/A
SHARES OUTSTANDING 
72.440 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
0.03
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$83,210
AVERAGE 30 VOLUME 
$29,800
Company detail
CEO: Francois Michelon
Region: US
Website: endrainc.com
Employees: 20
IPO year: 2017
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

ENDRA Life Sciences Inc. develops thermo-acoustic enhanced ultrasound technology. Technology transmits sound waves, which bounce off tissues, organs, and blood in the body. Thermoablative surgery, vascular imaging, and tissue perfusion technologies also offer diagnostic imaging technologies.

Recent news
loading